Quantcast

Latest OncoGenex Pharmaceuticals Inc. Stories

2014-02-25 08:30:53

BOTHELL, Wash. and VANCOUVER, British Columbia, Feb. 25, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's fourth quarter and year-ended 2013 financial results will be released on Tuesday, March 11, 2014, and that the Company will host a conference call and live webcast at 4:30 p.m. ET that afternoon. Management will provide an overview of the company's financial results, development programs and a general business update. To...

2014-02-11 08:30:37

BOTHELL, Wash. and VANCOUVER, British Columbia, Feb. 11, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced that the pre-specified number of events required for final analysis of the Phase 3 SYNERGY trial has been reached. The primary efficacy endpoint of SYNERGY will analyze overall survival benefit for custirsen in combination with standard first-line docetaxel chemotherapy and prednisone in men with metastatic castrate-resistant prostate cancer...

2014-02-06 08:27:24

BOTHELL, Wash. and VANCOUVER, British Columbia, Feb. 6, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that Scott Cormack, President and Chief Executive Officer, will provide a corporate presentation at the Leerink Global Healthcare Conference on Wednesday, February 12, 2014 at 8:50 a.m. ET at the Waldorf Astoria Hotel in New York City. A live audio webcast can be accessed through the Investor Relations page of the OncoGenex website at...


Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'